Polpharma is a pharmaceutical company that specializes in the development, production, and distribution of innovative and high-quality generic and branded pharmaceutical products.
Incorporated in 1936 as Zaklady Farmaceutyczne Polfa
Became the largest pharmaceutical company in Poland in the 1970s
Expanded internationally in the 1990s
Acquired by Enterprise Investors in 2001
Invested in modern production facilities and research capabilities
Expanded product portfolio and entered new markets
Established a strong presence in Central and Eastern Europe
Continues to focus on innovation, research, and development
Teva Pharmaceutical Industries is a multinational pharmaceutical company that specializes in the development, production, and distribution of generic and specialty medicines.
Novartis is a Swiss multinational pharmaceutical company that focuses on the research, development, and manufacturing of innovative healthcare products.
Pfizer is an American multinational pharmaceutical company that specializes in the development, production, and distribution of prescription drugs and vaccines.
Polpharma offers a wide range of high-quality generic pharmaceuticals for various therapeutic areas.
In addition to generics, Polpharma also develops and markets branded pharmaceutical products.
Polpharma has a growing portfolio of biological medicines, including biosimilars, that provide treatment options for various diseases.
Polpharma is known for its expertise in the development, production, and distribution of generic and branded pharmaceutical products.
Polpharma is headquartered in Starogard Gdanski, Poland.
Yes, Polpharma has expanded internationally and has a strong presence in Central and Eastern Europe.
Polpharma's products cover a wide range of therapeutic areas, including cardiovascular, respiratory, neurological, and immunological diseases.
Yes, Polpharma invests in research and development to continuously innovate and expand its product portfolio.